Sanders Tri-Institutional Therapeutics Discovery Institute, Inc. logo

Sanders Tri-Institutional Therapeutics Discovery Institute, Inc. Employee Directory

Biotechnology ResearchNew York, United States2-10 Employees

Sanders Tri-Institutional Therapeutics Discovery Institute, Inc. has about 10 employees across 3 continents, most of them in North America. By country, the largest groups are United States Of America (91%), Japan (5%) and Argentina (5%). Biotechnology and Consulting make up over half of the profiles with a known department. Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.'s workforce fell 63% between January 2026 and November 2026.

Find Sanders Tri-Institutional Therapeutics Discovery Institute, Inc. employees' phone numbers or email addresses

Sanders Tri-Institutional Therapeutics Discovery Institute, Inc. Global Highlights

Location
Employees

North America
20

Minus sign iconPlus sign icon
  • United States Of America
    20

Asia
1

Minus sign iconPlus sign icon
  • Japan
    1

South America
1

Minus sign iconPlus sign icon
  • Argentina
    1

North America accounts for 91% of Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.'s workforce, followed by Asia (5%) and South America (5%).

Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.'s Leadership

  • Owner at Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.
    R. L.
    Owner
  • Principal at Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.
    P. L.
    Principal
  • Research Associate Ii, Antibody Discovery at Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.
    B. N.
    Research Associate Ii, Antibody Discovery
  • Deerfield Management at Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.
    C. B.
    Deerfield Management

Sanders Tri-Institutional Therapeutics Discovery Institute, Inc. Employee Metrics

100%
50%
0%
2026
2025
  • Biotechnology
  • Business
  • Consulting
  • Program & Project Management
  • Sales
  • Other
  • Arts & Design
  • Media & Communications

Biotechnology is the largest department at 60% of profiles with a known department, up from 54% in January 2026, followed by Consulting (20%, up from 15%) and Media & Communications (20%, up from 0%).

Contact profiles from Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.

Name
Title
Contact
Location
Last Update
  • Owner at Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.
    R. L.
    Owner
    Oct 17, 2024
  • Principal at Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.
    P. L.
    Principal
    Oct 17, 2024
  • Research Associate Ii, Antibody Discovery at Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.
    B. N.
    Research Associate Ii, Antibody Discovery
    Oct 22, 2024
  • Deerfield Management at Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.
    C. B.
    Deerfield Management
    Oct 21, 2024

Frequently Asked Questions

What are the largest departments at Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.?

Minus sign iconPlus sign icon
Biotechnology is the largest department at 60% of profiles with a known department, up from 54% in January 2026, followed by Consulting (20%, up from 15%) and Media & Communications (20%, up from 0%).

Where are Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.'s employees located?

Minus sign iconPlus sign icon
Sanders Tri-Institutional Therapeutics Discovery Institute, Inc. has about 10 employees across 3 continents, most of them in North America. North America accounts for 91% of Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.'s workforce, followed by Asia (5%) and South America (5%). By country, the largest groups are United States Of America (91%), Japan (5%) and Argentina (5%).

How has Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.'s workforce changed over the past year?

Minus sign iconPlus sign icon
Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.'s workforce fell 63% between January 2026 and November 2026. Biotechnology's share of profiles with a known department rose from 54% to 60%.

How many employees does Sanders Tri-Institutional Therapeutics Discovery Institute, Inc. have currently?

Minus sign iconPlus sign icon
Sanders Tri-Institutional Therapeutics Discovery Institute, Inc. has approximately 10 employees as of November 2026. These team members are located across 3 continents, including North America, Asia and South America.

Who are Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.'s key employees and leadership?

Minus sign iconPlus sign icon

As of November 2026, Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.'s key employees include:

  • Owner: R. L.
  • Principal: P. L.
  • Research Associate Ii, Antibody Discovery: B. N.
  • Deerfield Management: C. B.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

What is Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.'s most common email format?

Minus sign iconPlus sign icon
Sanders Tri-Institutional Therapeutics Discovery Institute, Inc. employees' email format typically follows the pattern of FLast@tritdi.org. Trying to find reliable and up-to-date employee contact data? Find more Sanders Tri-Institutional Therapeutics Discovery Institute, Inc. email formats with LeadIQ.

What is Sanders Tri-Institutional Therapeutics Discovery Institute, Inc. known for?

Minus sign iconPlus sign icon
Sanders Tri-Institutional Therapeutics Discovery Institute, Inc. was founded in 2013 and operates in the Biotechnology Research industry. You can contact Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.'s main corporate office by phone at . Explore Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.'s company overview page for more information.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.